| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000005756 |
| Receipt No. | R000006804 |
| Official scientific title of the study | Clinical trial for the effect of beta2 adrenargic receptor polymorphism to long acting beta agonist induced hypokalemia. |
| Date of disclosure of the study information | 2011/06/13 |
| Last modified on | 2016/12/13 (Ver. 5) |
| Basic information | ||
| Official scientific title of the study | Clinical trial for the effect of beta2 adrenargic receptor polymorphism to long acting beta agonist induced hypokalemia. | |
| Title of the study (Brief title) | The effect of beta2 adrenargic receptor polymorphism to long acting beta agonist induced hypokalemia. | |
| Region |
|
|
| Condition | ||
| Condition | healthy adult | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | YES | |
| Objectives | |
| Narrative objectives1 | To evaluate whether the beta-receptor polymorphism affects to hypokalemia occurred after the Formoterol inhalation. |
| Basic objectives2 | Safety |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Serum potassium level after the Formoterol inhalation |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Cross-over |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Placebo |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 3 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | long acting beta agonist; Formoterol | |
| Interventions/Control_2 | Formoterol/ Budesonide complex | |
| Interventions/Control_3 | placebo | |
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The cases with a genetic polymorphism that results in homozygosity for arginine (Arg/Arg), or glycine (Gly/Gly), at aminoacid residue 16 of the beta2-adrenergic receptor.
The cases with normal range of serum potassium levels. |
|||
| Key exclusion criteria | Take any drugs.
Hypertension; Systolic pressure >160mmHg or diastolic blood pressure >90mmHg or heart rate> 85 a minute Past history of hypertension, heart failure, atrial fibrillation, and extrasystole arrythmia. Abnormalities of ECG ; QTc>0.45s Pointed out of the hepatic or renal functional abnormality, and diabetes. Cigarette smoker. Postsurgery of the lung. |
|||
| Target sample size | 40 | |||
| Research contact person | |
| Name of lead principal investigator | Ikkou HIGASHIMOTO |
| Organization | Kagoshima university Graduate school of medical and dental sciences |
| Division name | pulmonary medicine |
| Address | 8-35-1 Sakuragaoka Kagoshima, Japan |
| TEL | 0992657164 |
| ikkou@m2.kufm.kagoshima-u.ac.jp | |
| Public contact | |
| Name of contact person | Ikkou Higashimoto |
| Organization | Kagoshima university Graduate school of medical and dental science |
| Division name | Department of pulmonary medicine |
| Address | 8-35-1Sakuragaoka Kagoshima city, Japan |
| TEL | 0992756481 |
| Homepage URL | |
| ikkou@m2.kufm.kagoshima-u.ac.jp | |
| Sponsor | |
| Institute | Department of pulmonary medicine, Kagoshima university Graduate school of medical and dental sciences |
| Institute | |
| Department | |
| Funding Source | |
| Organization | none |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | 鹿児島大学病院 |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000006804 |